Exciting research in oncology is shifting toward a more personalized approach to cancer prevention and treatment –– starting ...

In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

Violin teacher Constance Meyer’s chronic hacking cough was driving other people crazy. The mother of a new student figured ...

The researchers found that having ever used oral contraception reduced odds of ovarian cancer by 26% (odds ratio [OR], 0.74; 95% CI, 0.66-0.84). Further, those who stopped using oral contraception at ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Brandi Muhle was 9 years old when her 35-year-old mother, an Omaha police officer and a marathon runner, was first diagnosed ...

NVIDIA (NASDAQ: NVDA) has introduced Evo 2, an advanced artificial intelligence (AI) system aimed at transforming the field ...

AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for ...

California-based nonprofit Arc Institute and Stanford University, in collaboration with NVIDIA, unveiled Evo 2 on Wednesday ...

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

During the Feb. 11 event, Chris Evert and Martina Navratilova discussed memorable tournaments, double dates and their ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.